Literature DB >> 22216529

Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers.

P H Joubert1, B N Aucamp, F O Müller.   

Abstract

After 1 week of baseline observations increasing oral doses of digoxin were administered to four healthy volunteers over a 6-7 week period. A dose-response relationship exists with regards to PTQ-changes (a quantitative measure of ECG-changes). PTQ-changes were related linearly to both serum and salivary digoxin levels. PTQ-changes appear to be useful as a non-invasive measure for studying various aspects of digoxin pharmacodynamics. Serial salivary digoxin levels might be a better index of the effect of cardiac glycosides than individual or serial serum levels.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216529      PMCID: PMC1428970          DOI: 10.1111/j.1365-2125.1976.tb00357.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Serial serum digoxin concentrations and quantitative electrocardiographic changes.

Authors:  P Joubert; B Kroening; M Weintraub
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  A correlative study of serum digoxin levels and electrocardiographic measurements.

Authors:  P H Joubert; F O Müller; D F Pansegrouw; P H Kleynhans
Journal:  S Afr Med J       Date:  1975-07-12

3.  Relationship between digoxin concentrations in serum and saliva.

Authors:  D H Huffman
Journal:  Clin Pharmacol Ther       Date:  1975-03       Impact factor: 6.875

Review 4.  Digitalis glycosides. Pharmacokinetics and their clinical implications.

Authors:  J E Doherty
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

5.  Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.

Authors:  A Redfors
Journal:  Br Heart J       Date:  1972-04

6.  Plasma digoxin concentrations in patients with atrial fibrillation.

Authors:  D A Chamberlain; R J White; M R Howard; T W Smith
Journal:  Br Med J       Date:  1970-08-22
  6 in total
  7 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Average parameters as a trend to reduce the residual variability in bioequivalence trials.

Authors:  P Fagiolino; M Vazquez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 4.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

5.  Relationship between inotropic changes and ECG changes induced by digitalis.

Authors:  P Joubert; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

6.  Digoxin, whole body potassium and the electrocardiogram.

Authors:  P H Joubert; F O Müller; F W van Rijssen; J Malan; M P Iturralde; O R van Reenen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

7.  [Digoxin induced changes in the exercise ECG and its relation to plasma concentrations (author's transl)].

Authors:  H R Ochs; H Otten; G Bodem
Journal:  Klin Wochenschr       Date:  1979-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.